JOURNAL ARTICLE
Routes of entry of squamous cell carcinoma to the mandible.
Head & Neck Surgery 1988 May
A recent preliminary report of a study to determine the patterns of invasion of squamous cell carcinoma to the nonirradiated edentulous mandible indicated that tumor entered mainly through the residual alveolar occlusal ridge. This study has now been extended and includes both nonirradiated and irradiated mandibles. Of a total of 46 nonirradiated mandibles (10 partially dentate and 36 edentulous) invaded by tumor, 41 were invaded through the occlusal surface. This confirms the findings of the preliminary report. These findings indicate that there is a rational basis on pathologic grounds for adopting a conservative approach to the nonirradiated mandible. In 16 irradiated mandibles, the routes of tumor entry were found to be much more variable than in the nonirradiated mandible. In 16 irradiated mandibles, the routes of tumor entry were found to be much more variable than in the nonirradiated mandible, and multiple foci of tumor invasion of the bone were often present wherever tumor in adjacent soft tissues approached the bone. This variability of tumor entry means that a conservative approach to mandibular excision cannot be pursued in the previously irradiated mandible and full-thickness segmental resection is necessary if bone involvement appears likely.
Full text links
Trending Papers
Migraine.Annals of Internal Medicine 2023 January 11
How to diagnose iron deficiency in chronic disease: A review of current methods and potential marker for the outcome.European Journal of Medical Research 2023 January 10
Long COVID: major findings, mechanisms and recommendations.Nature Reviews. Microbiology 2023 January 14
Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology.Swiss Medical Weekly 2023 January 7
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app